BEUDAMED
    FDA PMA 30-Day Notice Accepted 🇺🇸 United States

    PMA: P010031 · Supplement: S229 · Decision Feb 3, 2011
    View on FDA
    Classifications
    0
    FEI Numbers
    0
    Registration Numbers
    0

    Basic Information

    Trade Name
    CONSULTA/CONSULTA II/MAXIMO II/CONCERTO CRT-DS
    PMA Number
    P010031
    Supplement Number
    S229
    Advisory Committee
    Cardiovascular
    Decision
    30-Day Notice Accepted
    Decision Code
    OK30
    Decision Date
    February 3, 2011
    Date Received
    January 5, 2011
    Supplement Type
    30-Day Notice
    Supplement Reason
    Process Change - Manufacturer/Sterilizer/Packager/Supplier
    Expedited Review
    N

    Advisory Committee Statement

    REDUCTION IN THE FREQUENCY OF A QUALITY CONTROL TEST FOR THE LASER RIBBON BONDING (LRB) PROCESS.